跳至主要内容
临床试验/IRCT2016101530309N1
IRCT2016101530309N1已完成2 期

Comparison of the effect of Bisphosphonate on the prevention of type 2 diabetes among Osteopenic menopause prediabetes women and Referred to Isfahan Endocrine and Metabolism Research Center.

Vice chancellor for research, Isfahan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 years 至 60 years(—)
性别
Female

入选标准

  • Inclusion and exclusion criteria
  • Inclusion criteria
  • Prediabetes and menopause female patients who are resistant to insulin at age between 45 to 60 will be included if fulfilling the following two criteria:
  • Osteopenia based on bone density measured by DAX machine Hologic 2008 model; Written consent by the patient to participate in the study obtained at the baseline
  • Exclusion criteria
  • Patients fulfilling any of the following criteria will be excluded from the study; Failure to use vitamin of OTC or trace element; Patients who do not like to continue with the study for any reason; Patients who take drugs that affect metabolism of glucose; The Osteoporotic patient; Patients with kidney failure problem.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Isfahan University of Medical Sciences

相似试验

已完成
不适用
Effect of treatment with an oral bisphosphonate on markers of bone formation and bone resorption in adults with alkpatonuria
ISRCTN12672997niversity Medical Centre Utrecht (UMCU) (The Netherlands)6
进行中(未招募)
1 期
Brittle bones - do they react normally after treatment with bisphosphonates?Osteogenesis ImperfectaMedDRA version: 19.0Level: PTClassification code 10031243Term: Osteogenesis imperfectaSystem Organ Class: 10010331 - Congenital, familial and genetic disorders
EUCTR2016-003606-14-GBSheffield Children's NHS Foundation Trust15
招募中
不适用
The Effect of Bisphosphonates on the Immune System in Adults With OsteoporosisImmune systemMusculoskeletal - OsteoporosisInflammatory and Immune System - Other inflammatory or immune system disordersOsteoporosis
ACTRN12614000300673Bone Research Group, Garvan Institute of Medical Research44
已完成
不适用
The effects of bisphosphonates on disease activity and bone status in ankylosing spondylitis (BIAS)Ankylosing Spondylitis (AS)Musculoskeletal Diseases
ISRCTN87639321Royal National Hospital for Rheumatic Diseases (UK)180
进行中(未招募)
不适用
Effects of drug treatment with bisphosphonates (zoledronic acid) in the prevention of skeletal events in breast cancer patients with osteoporosis. Significant correlation with some biological parameters - NDMedDRA version: 12.1Level: LLTClassification code 10057654Term: Breast cancer femaleBreast cancer
EUCTR2010-019216-20-ITAZIENDA OSPEDALIERO UNIVERSITARIA DI CAGLIARI